期刊文献+

尼可地尔对急性心肌梗死患者短期预后的影响 被引量:8

The Influence of Short-term Prognosis by Nicoradil Treatment on Patients with Acute Myocardial Infarction(AMI)
下载PDF
导出
摘要 目的:研究缺血预处理对ST抬高的急性心肌梗死患者短期预后的影响。方法:采用随机、临床对照实验方法。选择确诊为ST抬高的急性心肌梗死患者90例作为研究对象。随机分为3组,即尼可地尔(钾通道开放剂)低剂量治疗组、尼可地尔高剂量治疗组以及对照组,每组各30例,3组患者均接受ST抬高的急性心肌梗死标准治疗,其中尼可地尔治疗组在标准方案基础上加用尼可地尔。研究主要终点为治疗后CK、CKMB、LDH的峰值活性和EF值,研究次要终点为住院期间泵衰竭的发生率、恶性心律失常的发生率以及各组缺血区室壁运动。结果:2组尼可地尔治疗组分别与对照组两两比较均有较低的酶峰值活性,较高的EF值,住院期间泵衰竭、恶性心律失常的发生概率均较低,而缺血区室壁运动障碍较小(均P<0.05)。而尼可地尔高低剂量组各指标之间均无显著性差异(P>0.05)。结论:尼可地尔可改善急性心肌梗死患者的短期预后,而尼可地尔增加服用剂量有益性并不增加。 Objective:To study the influence of short-term prognosis on AMI patients with ischemin treatment. Methods:Take the method of radom and clinical control experiment. Ninety patients of chest pain were diagnosed ST-elevation AMI, divided into three groups according to whether or not oral nicoradil therapy and dosage, including low-dosage, high-dosage therapy group and control group. Each group is 30 cases. All patients were treated the normal therapy of ST-elevation AMI. The two nicoradil therapy group not only take the normal therapy , but also nicoradil. The primary end point of the study ws to measure the quantity of creatine kinase, MB creatine kinase , L-lactate dehydrogenase and eject fraction of left ventricular after therapy.The secondary end point was incidence of left heart failure and malignant ventrieular arrhymia, ventricular movement of ischemic area in hospitalization. Results:The peak value of CK, CKMB, LDH and incidence of left heart failure, malignant ventricular arrhythmia and the ventrieular movement ahnormity in the group of oral nicorandil therapy were lower than contral group. And the EF value were higher than control group, P〈0.05. All the numerical value of two therapy group have not significance difference, P〈0.05. Conclusion:Nicoradil can improve the short-term prognosis of the patients with AMI. Incremental dosage of nicoradil does not improve short-term prognosis.
作者 王秀娟
出处 《中国临床医学》 2009年第3期344-345,共2页 Chinese Journal of Clinical Medicine
关键词 急性心肌梗死 缺血预处理 尼可地尔 AMI Ischemic treatment Nicoradil
  • 相关文献

参考文献4

二级参考文献8

  • 1金惠铭.病理生理学(第5版)[M].北京:人民卫生出版社,2001.99.
  • 2Lepran, L Baczko, I Varro, et al. ATP sensitive potassium channel modulators:both pinacidil and gliben clamide produce antiarrhythmic activity during acute myocardial infarction in conscious rats[J] .J Pharmacol Exp Ther,1996,277:1215 - 1220.
  • 3Reimer KA,Van der Heide RS,Richard VJ.Reperfusion in acute myocardial infarction:fect of timing and modulating factors in experimental. model[J].Am J Cardiol, 1993,72:13.
  • 4Yang XP, Liu YH, Peterson E, et al. Effect of neutral endopeptidase 24.11inhibition on myocardial ischemia/reperfusion injury,the role of kinins [J].J Cardiovasc Pharmacol, 1997,29:250.
  • 5Fukuda H, Luo CS, Gu X, et al. The effect of K(ATP ) channel activation on myocardial cationic and energetic status during ischemia and reperfusion:role in cardiopro tection[J] .J Mol Cell Cardiol,2001,33(3) :545 - 560.
  • 6Gross GJ, Acuhampach JA.Blockade of ATP2 sensitive potassium channels prevents myocardial preconditioning in dogs [J] . Circ Res, 1992, 70 (2):223 - 233.
  • 7王淑侠,兰小莉,王吉文,裴著果.大鼠心肌缺血/再灌注损伤模型的改进与评价[J].解剖科学进展,2000,6(4):371-373. 被引量:76
  • 8YIN XIAO-MING (Department of Pathology, University of Pittsburgh School of Medicine, 3550 Terrace Street, Pittsburgh, PA 15261, USA).Signal transduction mediated by Bid,a pro-death Bcl-2 family proteins, connects the death receptor and mitochondria apoptosis pathways[J].Cell Research,2000,10(3):161-167. 被引量:25

共引文献85

同被引文献62

  • 1吴耀辉,王梦洪.尼可地尔对心肌缺血再灌注心律失常发生率的影响[J].四川医学,2005,26(11):1320-1321. 被引量:4
  • 2董振明,罗友军,康荣田,任建军.尼可地尔预先给药对心肌缺血再灌注兔心肌细胞凋亡的影响[J].中华麻醉学杂志,2005,25(10):747-750. 被引量:9
  • 3急性心肌梗塞溶栓疗法参考方案(1996年7月修订)[J].中华心血管病杂志,1996,24(5):328-329. 被引量:1321
  • 4Murry CE,Jennings RB,Reimer KA.Preconditioning with ischemia:a delay of lethal cell injury in ischemic myocardium.Circulation,1986,74(5):1124-1136.
  • 5田金飞 汤彦 周心涛等.初发急性心肌梗死与再梗死危险因素分析[J].中国医师进修杂志,2007,30(2):26-25.
  • 6The IONA Study Group.Effect of nicorandil on coronary events in patients with stable angina:the Impact of Nicorandil in Angina(IONA) randomised trial[J].Lancet,2002,359(9314):1269-1275.
  • 7Matsuo H,Watanabe S,Segawa T,et al.Evidence of pharmacologic preconditioning during PTCA by intravenous pretreatment with ATP-sensitive K+ channel opener nicorandil[J].Eur Heart J,2003,24(14):1296-1303.
  • 8Ishida H,Higashijima N,Hirota Y,et al.Nicorandil attenuates the mitochondrial Ca2+ overload with accompanying depolarization of the mitochondrial membrane in the heart[J].Naunyn Schmiedebergs Arch Pharmacol,2004,369(2):192-197.
  • 9Nameki M,Ishibashi I,Miyazaki Y,et al.Comparison between nicorandil and magnesium as an adjunct cardioprotecti veagent to percutaneous coronary intervention in acute anterior myocardial infarction[J].Circ J,2004,68(3):192-197.
  • 10IONA Study Group.Determinants of coronary events in patients with stable angina:results from the impact of nicorandil in angina study[J].Am Heart J,2005,150(4):689.

引证文献8

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部